000 | 01460ngm a2200361 a 4500 | ||
---|---|---|---|
001 | HST5734 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 220904s2022 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a5734 _bHenry Stewart Talks |
035 | _a(UkLoHST)5044 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aCox, Jonathan A. G., _u(Aston University, UK) _4spk |
|
245 | 1 | 0 |
_aStrengths and limitations of phenotypic drug discovery _h[electronic resource] / _cJonathan A.G. Cox. |
260 |
_aLondon : _bHenry Stewart Talks, _c2022. |
||
300 |
_a1 online resource (1 streaming video file (29 min.) : _bcolor, sound). |
||
490 | 1 |
_aThe biomedical & life sciences collection, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Why we need new antibiotics -- Different approaches to drug discovery -- Phenotypic drug discovery -- Limitations of phenotypic drug discovery. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aAntibiotics _xDevelopment. |
|
650 | 0 | _aDrug development. | |
650 | 2 | _aAnti-Bacterial Agents. | |
650 | 2 | _aDrug Discovery. | |
650 | 2 | _aPharmaceutical Preparations. | |
650 | 2 | _aPhenotype. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/5044/ |
999 |
_c75501 _d75501 |